Profenamina [Italian]

Profenamina [Italian] Brand names, Profenamina [Italian] Analogs

Profenamina [Italian] Brand Names Mixture

No information avaliable

Profenamina [Italian] Chemical_Formula

C₁₉H₂₄N₂S

Profenamina [Italian] RX_link

No information avaliable

Profenamina [Italian] fda sheet

Profenamina [Italian] msds (material safety sheet)

Profenamina [Italian] Synthesis Reference

No information avaliable

Profenamina [Italian] Molecular Weight

312.473 g/mol

Profenamina [Italian] Melting Point

64.5 ^oC

Profenamina [Italian] H₂O Solubility

0.693 mg/L

Profenamina [Italian] State

Solid

Profenamina [Italian] LogP

5.772

Profenamina [Italian] Dosage Forms

Tablet (10 mg); Tablet (scored, 50 mg)

Profenamina [Italian] Indication

For use in the treatment of Parkinson's disease and also used to control severe reactions to certain medicines such as reserpine.

Profenamina [Italian] Pharmacology

Ethopropazine, a phenothiazine and antidyskinetic, is used in the treatment of Parkinson's disease. By improving muscle control and reducing stiffness, this drug permits more normal movements of the body as the disease symptoms are reduced. It is also used to control severe reactions to certain medicines such as reserpine, phenothiazines, chlorprothixene, thiothixene, loxapine, and haloperidol. Unlike other NMDA antagonists, ethopropazine — because of its anticholinergic action — is largely devoid of neurotoxic side effects. Ethopropazine also has a slight antihistaminic and local anesthetic effect.

Profenamina [Italian] Absorption

Well-absorbed from the gastrointestinal tract.

Profenamina [Italian] side effects and Toxicity

Symptoms of overdose include severe clumsiness or unsteadiness, severe drowsiness, severe dryness of mouth, nose, or throat, fast heartbeat, shortness of breath or troubled breathing, and warmth, dryness, and flushing of skin.

Profenamina [Italian] Patient Information

Profenamina [Italian] Organisms Affected

Humans and other mammals